BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 21976640)

  • 1. Virus-host coevolution in a persistently coxsackievirus B3-infected cardiomyocyte cell line.
    Pinkert S; Klingel K; Lindig V; Dörner A; Zeichhardt H; Spiller OB; Fechner H
    J Virol; 2011 Dec; 85(24):13409-19. PubMed ID: 21976640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a new mouse model for coxsackievirus-induced myocarditis by attenuating coxsackievirus B3 virulence in the pancreas.
    Pinkert S; Pryshliak M; Pappritz K; Knoch K; Hazini A; Dieringer B; Schaar K; Dong F; Hinze L; Lin J; Lassner D; Klopfleisch R; Solimena M; Tschöpe C; Kaya Z; El-Shafeey M; Beling A; Kurreck J; Van Linthout S; Klingel K; Fechner H
    Cardiovasc Res; 2020 Aug; 116(10):1756-1766. PubMed ID: 31598635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of coxsackievirus-B3-infected BALB/c mice with the soluble coxsackie adenovirus receptor CAR4/7 aggravates cardiac injury.
    Dörner A; Grunert HP; Lindig V; Chandrasekharan K; Fechner H; Knowlton KU; Isik A; Pauschinger M; Zeichhardt H; Schultheiss HP
    J Mol Med (Berl); 2006 Oct; 84(10):842-51. PubMed ID: 16924471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of a Large-Plaque Variant in Mice Infected with Coxsackievirus B3.
    Wang Y; Pfeiffer JK
    mBio; 2016 Mar; 7(2):e00119. PubMed ID: 27025249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis.
    Müller I; Vogl T; Pappritz K; Miteva K; Savvatis K; Rohde D; Most P; Lassner D; Pieske B; Kühl U; Van Linthout S; Tschöpe C
    Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29158436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble recombinant coxsackievirus and adenovirus receptor abrogates coxsackievirus b3-mediated pancreatitis and myocarditis in mice.
    Yanagawa B; Spiller OB; Proctor DG; Choy J; Luo H; Zhang HM; Suarez A; Yang D; McManus BM
    J Infect Dis; 2004 Apr; 189(8):1431-9. PubMed ID: 15073680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiomyocyte apoptosis in experimental coxsackievirus B3 myocarditis.
    Saraste A; Arola A; Vuorinen T; Kytö V; Kallajoki M; Pulkki K; Voipio-Pulkki LM; Hyypiä T
    Cardiovasc Pathol; 2003; 12(5):255-62. PubMed ID: 14507574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
    Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H
    Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phosphorothioate antisense oligodeoxynucleotide specifically inhibits coxsackievirus B3 replication in cardiomyocytes and mouse hearts.
    Yuan J; Cheung PK; Zhang H; Chau D; Yanagawa B; Cheung C; Luo H; Wang Y; Suarez A; McManus BM; Yang D
    Lab Invest; 2004 Jun; 84(6):703-14. PubMed ID: 15094712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent Coxsackievirus B3 Infection in Pancreatic Ductal Cells
    Mastrodomenico V; LoMascolo NJ; Firpo MR; Villanueva Guzman MDM; Zaporowski A; Mounce BC
    mSphere; 2023 Jun; 8(3):e0003623. PubMed ID: 37097178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interspecies differences in virus uptake versus cardiac function of the coxsackievirus and adenovirus receptor.
    Freiberg F; Sauter M; Pinkert S; Govindarajan T; Kaldrack J; Thakkar M; Fechner H; Klingel K; Gotthardt M
    J Virol; 2014 Jul; 88(13):7345-56. PubMed ID: 24741103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific interactions of mouse organ proteins with the 5'untranslated region of coxsackievirus B3: potential determinants of viral tissue tropism.
    Cheung PK; Yuan J; Zhang HM; Chau D; Yanagawa B; Suarez A; McManus B; Yang D
    J Med Virol; 2005 Nov; 77(3):414-24. PubMed ID: 16173012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA.
    Kim KS; Tracy S; Tapprich W; Bailey J; Lee CK; Kim K; Barry WH; Chapman NM
    J Virol; 2005 Jun; 79(11):7024-41. PubMed ID: 15890942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human astrocytic cells support persistent coxsackievirus B3 infection.
    Zhang X; Zheng Z; Shu B; Liu X; Zhang Z; Liu Y; Bai B; Hu Q; Mao P; Wang H
    J Virol; 2013 Nov; 87(22):12407-21. PubMed ID: 24027313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of Endoplasmic Reticulum Stress-Mediated C/EBP Homologous Protein Activation in Coxsackievirus B3-Induced Acute Viral Myocarditis.
    Cai Z; Shen L; Ma H; Yang J; Yang D; Chen H; Wei J; Lu Q; Wang DW; Xiang M; Wang J
    Circ Heart Fail; 2015 Jul; 8(4):809-18. PubMed ID: 25985795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astragaloside IV exerts antiviral effects against coxsackievirus B3 by upregulating interferon-gamma.
    Zhang Y; Zhu H; Huang C; Cui X; Gao Y; Huang Y; Gong W; Zhao Y; Guo S
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):190-5. PubMed ID: 16495755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection.
    Slifka MK; Pagarigan R; Mena I; Feuer R; Whitton JL
    J Virol; 2001 Mar; 75(5):2377-87. PubMed ID: 11160741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human cardiac-derived adherent proliferating cells reduce murine acute Coxsackievirus B3-induced myocarditis.
    Miteva K; Haag M; Peng J; Savvatis K; Becher PM; Seifert M; Warstat K; Westermann D; Ringe J; Sittinger M; Schultheiss HP; Tschöpe C; Van Linthout S
    PLoS One; 2011; 6(12):e28513. PubMed ID: 22174827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Model Systems of Coxsackievirus B3-Induced Myocarditis: Comparison of Commonly Used Cell Lines and Characterization of CVB3-Infected iCell
    Kraft L; Sauter M; Seebohm G; Klingel K
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coxsackievirus B3 engineered to contain microRNA targets for muscle-specific microRNAs displays attenuated cardiotropic virulence in mice.
    He F; Yao H; Wang J; Xiao Z; Xin L; Liu Z; Ma X; Sun J; Jin Q; Liu Z
    J Virol; 2015 Jan; 89(2):908-16. PubMed ID: 25339771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.